Strategic Financial Concepts LLC Purchases Shares of 27,168 SPDR S&P Biotech ETF (NYSEARCA:XBI)

Strategic Financial Concepts LLC purchased a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 27,168 shares of the exchange traded fund’s stock, valued at approximately $2,447,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Healthcare of Ontario Pension Plan Trust Fund raised its stake in SPDR S&P Biotech ETF by 198.6% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after buying an additional 6,138,000 shares during the period. Clal Insurance Enterprises Holdings Ltd acquired a new position in SPDR S&P Biotech ETF during the 3rd quarter worth approximately $141,284,000. Assetmark Inc. raised its stake in SPDR S&P Biotech ETF by 72,653.0% during the 3rd quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock worth $58,223,000 after buying an additional 588,489 shares during the period. Sivik Global Healthcare LLC acquired a new position in SPDR S&P Biotech ETF during the 3rd quarter worth approximately $29,640,000. Finally, Mirae Asset Securities USA Inc. raised its stake in shares of SPDR S&P Biotech ETF by 50.0% in the third quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock worth $88,920,000 after purchasing an additional 300,000 shares during the last quarter.

SPDR S&P Biotech ETF Stock Down 1.0 %

Shares of SPDR S&P Biotech ETF stock opened at $90.34 on Tuesday. The company has a market cap of $6.89 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 52 week low of $81.14 and a 52 week high of $105.47. The business has a 50 day moving average price of $92.40 and a 200-day moving average price of $96.38.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.